Hybrid Molecular MR Imaging, PET Biomarkers Technology to Be Presented at UK Meeting

The same size of a traditional 3T MRI scanner, it acquires MR functional data in human tissue and PET cellular activity in a simultaneous procedure.

The Symbia single photon computed tomography/computed tomography (SPECT/CT) product range combines SPECT dual-detector variable angle gamma camera with multislice-CT capabilities for neurology, oncology, and cardiology applications.

Siemens Healthcare (Erlangen, Germany) is highlighting the capabilities of its Biograph mMR and Symbia SPECT/CT product range at the British Nuclear Medicine Society’s (BNMS) annual meeting, which takes place between 29th April 29 to May 2, 2012 in Harrogate, UK. PETNET Solutions, a division of Siemens plc, will present recent performance figures, establishing it as a leading supplier of PET biomarkers in the United Kingdom in terms of volume, range, and performance.

“Precision and accuracy are two key requirements in molecular imaging demanded by clinicians. Siemens Healthcare is proud to offer information on our Biograph mMR and Symbia SPECT/CT range of systems at the BNMS annual meeting,” commented Lawrence Foulsham, molecular imaging product manager at Siemens Healthcare. “Our range delivers precision for accurate diagnosis and treatment planning, plus offers workflow advantages improving throughput and cost of ownership.”

PETNET Solutions operate two PET manufacturing and distribution sites in the United Kingdom at Mount Vernon Hospital and Nottingham City Hospital. It produces more than 20,000 doses of PET biomarkers per year with a reliability rate of on-time deliveries in excess of 99.7%. The two sites provide wide UK coverage to support clinical and research PET imaging facilities.

The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology (IT), and hearing aids.

Related Links:
Siemens Healthcare